Cardiopulmonary bypass in patients with pre-existing coagulopathy

William DeBois1, Junli Liu, Leonard Lee

  • 1New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York 10021, USA. wdebois@nyp.org

Insights

Patients with bleeding disorders undergoing cardiac surgery face higher risks. Proper pre-operative screening and management of coagulopathies are crucial for preventing serious complications during cardiopulmonary bypass.

Area of Science:

  • Cardiovascular Surgery
  • Hematology
  • Anesthesiology

Background:

  • Pre-existing coagulopathies increase bleeding risk in surgical patients.
  • Cardiac surgery with cardiopulmonary bypass (CPB) exacerbates this risk due to heparinization and extracorporeal circuits affecting blood components.

Purpose of the Study:

  • To review cardiac surgeries in patients with specific pre-existing coagulopathies.
  • To inform future management strategies for these complex patient cases undergoing CPB.

Main Methods:

  • Review of cases involving cardiac surgeries in patients with pre-existing coagulopathies.
  • Summary of management approaches and outcomes.

Main Results:

  • Pre-existing coagulopathies include antithrombin III deficiency, heparin-induced thrombocytopenia, cancer, factor XII deficiency, hemophilia, idiopathic thrombocytopenic purpura, protein S deficiency, and drug-induced platelet inhibition.
  • Unrecognized or poorly managed coagulopathies can lead to severe complications during open-heart surgery.

Conclusions:

  • Routine coagulation work-up and thorough medical history are essential for patients undergoing cardiac procedures.
  • Early diagnosis and appropriate management of coagulopathies are critical for improving surgical outcomes and reducing long-term morbidity.